SCHEMBL7005993

SCHEMBL7005993

COC(CNc1ccc(F)c(O)c1)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 2/20 0.43
ADRA2A P08913 2/20 0.43
ADRA2B P18089 2/20 0.43
ADRA2C P18825 2/20 0.43
ADRB1 P08588 1/20 0.43
EGFR P00533 2/20 0.39
RIPK2 O43353 1/20 0.39
RET P07949 1/20 0.39
KIF5B P33176 1/20 0.39
KDR P35968 1/20 0.39
NOD1 Q9Y239 1/20 0.39
CA3 P07451 1/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CA5B Q9Y2D0 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6216871 0.81 MAPT (0.41) KDM4EMEN1CYP3A4MAPTCYP2C9
SCHEMBL1728733 0.75 CA1 (0.47) EGFRCA9CA14KDM4EMEN1
SCHEMBL241292 0.75 MAPT (0.41) RETKDM4EMEN1MAPTKMT2A
SCHEMBL6908940 0.71 ALDH1A1 (0.33) MEN1MAPTKMT2A
SCHEMBL6584102 0.70 ALDH1A1 (0.44) KDM4EMEN1MAPTALOX15KMT2A
SCHEMBL19411103 0.69 MAPT (0.38) KDM4EMEN1CYP3A4MAPTCYP2C9
SCHEMBL10080364 0.68 CA3 (0.45) ADRB3ADRA2AADRA2BADRA2CADRB1
SCHEMBL484019 0.68 GAA (0.48) KDM4EMAPTALOX15KMT2A
SCHEMBL11079274 0.68 MAPT (0.58) CYP3A4MAPTCYP2C9CYP2C19NPSR1
SCHEMBL19431843 0.68 UTS2R (0.42) KDM4EMEN1MAPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1309551-A1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2003-05-14 EP disclosed
WO-2002014273-A1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM P.L.C. (GB) 2002-02-21 WO disclosed